* Rockwell Medical Inc RMTI.OQ reported a quarterly
adjusted
loss of 10 cents per share for the quarter ended in March. The
mean expectation of two analysts for the quarter was for a loss
of 16 cents per share.
* Revenue rose 22% to $19.67 million from a year ago;
analysts
expected $19.12 million.
* Rockwell Medical Inc's reported EPS for the quarter was a
loss
of 10 cents.
* The mean earnings estimate of analysts had risen by
about 41.1%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* Rockwell Medical Inc shares had risen by 35.4% this
quarter and
gained 141.4% so far this year.
* The company reported a quarterly loss of $1.75 million.
* Wall Street's median 12-month price target for Rockwell
Medical
Inc is $5.50
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data May
15 at 11:01 a.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2023 -0.16 -0.10 Beat
Dec. 31 2022 -0.39 -0.20 Beat
Sep. 30 2022 -0.48 -0.40 Beat
Jun. 30 2022 -0.81 -0.56 Beat